| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Antifungal agents| 1 | 2004 | Combination antifungal therapy. | 
| + | - | nl | Antimicrob Agents Chemother 48(3):693-715 (2004) |
| 2 | 1996 | Antifungal agents: chemotherapeutic targets and immunologic strategies. |
| + | - | nl | Antimicrob Agents Chemother 40(2):279-91 (1996) |
| 3 | 2008 | New and emerging treatments for fungal infections. | 
| + | - | nl | J Antimicrob Chemother 61 Suppl 1(-):i19-30 (2008) |
| 4 | 1999 | The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents. |
| + | - | nl | J Antimicrob Chemother 44(2):151-62 (1999) |
| 5 | 2005 | Combination treatment of invasive fungal infections. |
| + | - | nl | Clin Microbiol Rev 18(1):163-94 (2005) |
| 6 | 1999 | Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. |
| + | - | nl | Clin Microbiol Rev 12(4):583-611 (1999) |
| 7 | 1999 | Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. |
| + | - | nl | Clin Microbiol Rev 12(4):501-17 (1999) |
| 8 | 1999 | Current and emerging azole antifungal agents. |
| + | - | nl | Clin Microbiol Rev 12(1):40-79 (1999) |
| 9 | 1998 | Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. |
| + | - | nl | Clin Microbiol Rev 11(2):382-402 (1998) |
| 10 | 1993 | Compounds active against cell walls of medically important fungi. |
| + | - | nl | Clin Microbiol Rev 6(1):1-21 (1993) |
| 11 | 1988 | Overview of medically important antifungal azole derivatives. |
| + | - | nl | Clin Microbiol Rev 1(2):187-217 (1988) |
| 12 | 2004 | History of the development of azole derivatives. |
| + | - | nl | Clin Microbiol Infect 10 Suppl 1(-):1-10 (2004) |
| 13 | 2001 | Antifungal proteins. |
| + | - | nl | Appl Environ Microbiol 67(7):2883-94 (2001) |
| 14 | 1995 | Mechanisms of resistance to azole antifungals. |
| + | - | nl | Acta Biochim Pol 42(4):509-16 (1995) |
| 15 | 1995 | Ergosterol biosynthesis inhibition: a target for antifungal agents. |
| + | - | nl | Acta Biochim Pol 42(4):465-79 (1995) |
| 16 | 1995 | Fungal glycoproteins and their biosynthetic pathway as potential targets for antifungal agents. |
| + | - | nl | Acta Biochim Pol 42(4):505-8 (1995) |
| 17 | 2006 | Of yeasts and hyphae: a hematologist's approach to antifungal therapy. |
| + | - | nl | Hematology Am Soc Hematol Educ Program -(-):361-7 (2006) |
| 18 | 2007 | Antifungal agents. |
| + | - | nl | Med J Aust 187(7):404-9 (2007) |
| 19 | 2010 | Problems and hopes in the development of drugs targeting the fungal cell wall. |
| + | - | nl | Expert Rev Anti Infect Ther 8(4):359-64 (2010) |
| 20 | 2009 | Antifungal peptides secreted by filamentous fungi as promising new agents in human therapy. |
| + | - | nl | Future Microbiol 4(3):261-3 (2009) |
| 21 | 2009 | New antifungal agents in pediatric practice. |
| + | - | nl | Indian Pediatr 46(3):225-31 (2009) |
